Opportunities for Overcoming Mycobacterium tuberculosis Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy

被引：48

作者：

Torfs, Eveline ^{[1
]}

Piller, Tatiana ^{[1
]}

Cos, Paul ^{[1
]}

Cappoen, Davie ^{[1
]}

机构：

[1] Univ Antwerp, Dept Pharmaceut Sci, LMPH, Univ Pl 1, B-2610 Antwerp, Belgium

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2019年 / 20卷 / 12期

关键词：

Mycobacterium tuberculosis; drug resistance; antimycobacterial; novel targets; non-lethal targets; host-directed therapy; LEAD OPTIMIZATION; ATP SYNTHASE; POTENT INHIBITORS; INNATE IMMUNITY; DISCOVERY; CANDIDATE; AUTOPHAGY; GENES; IDENTIFICATION; MYCOTHIOL;

D O I：

10.3390/ijms20122868

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The ever-increasing incidence of drug-resistant Mycobacterium tuberculosis infections has invigorated the focus on the discovery and development of novel treatment options. The discovery and investigation of essential mycobacterial targets is of utmost importance. In addition to the discovery of novel targets, focusing on non-lethal pathways and the use of host-directed therapies has gained interest. These adjunctive treatment options could not only lead to increased antibiotic susceptibility of Mycobacterium tuberculosis, but also have the potential to avoid the emergence of drug resistance. Host-directed therapies, on the other hand, can also reduce the associated lung pathology and improve disease outcome. This review will provide an outline of recent opportunities.

引用

页数：23

共 148 条

[1] Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-γ and TNF-α positive T cell subsets in pulmonary tuberculosis [J].

Anand, S. Prabhu ;

Selvaraj, P. ;

Narayanan, P. R. .

CYTOKINE, 2009, 45 (02) :105-110

[2] To be or not to be exclusive: the sutezolid story [J].

Andrews, Jane .

LANCET GLOBAL HEALTH, 2016, 4 (02) :E89-E90

[3] A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis [J].

Andries, K ;

Verhasselt, P ;

Guillemont, J ;

Göhlmann, HWH ;

Neefs, JM ;

Winkler, H ;

Van Gestel, J ;

Timmerman, P ;

Zhu, M ;

Lee, E ;

Williams, P ;

de Chaffoy, D ;

Huitric, E ;

Hoffner, S ;

Cambau, E ;

Truffot-Pernot, C ;

Lounis, N ;

Jarlier, V .

SCIENCE, 2005, 307 (5707) :223-227

[4] Mycolic acids: Structure, biosynthesis and physiological functions [J].

Barry, CE ;

Lee, RE ;

Mdluli, K ;

Sampson, AE ;

Schroeder, BG ;

Slayden, RA ;

Yuan, Y .

PROGRESS IN LIPID RESEARCH, 1998, 37 (2-3) :143-179

[5]

Basak S., 2012, ANTIMICROB AGENTS CH, V57, P168

[6] Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis [J].

Belisle, JT ;

Vissa, VD ;

Sievert, T ;

Takayama, K ;

Brennan, PJ ;

Besra, GS .

SCIENCE, 1997, 276 (5317) :1420-1422

[7] Autophagy in the Fight Against Tuberculosis [J].

Bento, Carla F. ;

Empadinhas, Nuno ;

Mendes, Vitor .

DNA AND CELL BIOLOGY, 2015, 34 (04) :228-242

[8] DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis [J].

Boshoff, HIM ;

Reed, MB ;

Barry, CE ;

Mizrahi, V .

CELL, 2003, 113 (02) :183-193

[9]

Bourigault ML, 2013, AM J CLIN EXP IMMUNO, V2, P124

[10] Mycobacterial Membrane Proteins QcrB and AtpE: Roles in Energetics, Antibiotic Targets, and Associated Mechanisms of Resistance [J].

Bown, Luke ;

Srivastava, Santosh K. ;

Piercey, Brandon M. ;

McIsaac, Clarissa K. ;

Tahlan, Kapil .

JOURNAL OF MEMBRANE BIOLOGY, 2018, 251 (01) :105-117

← 1 2 3 4 5 6 7 8 9 10 →